Intrusion Inc. INTZ 深 滬
交易中 06-25 10:16:39 美东时间
0.6852
+0.004
+0.62%
華盛通- 最 高0.699
- 今 開0.687
- 成交量 4.27万股
- 最 低 0.6802
- 昨 收 0.681
- 總市值 1395.69万
- 52周最高 2.64
- 市盈率 靜 --
- 換手率 0.21%
- 52周最低 0.68
- 委 比 66.67%
- 總股本 2036.91万
- 歷史最高 598.00
- 量 比 4.45
- 振 幅 2.76%
- 歷史最低 0.68
- 每 手 1
- 風險率 0.48%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Intrusion Earnings Call: High Margins Amid Steep Drop
Intrusion (($INTZ)) has held its Q1 earnings call. Read on for the main highlig...
06-02 08:25
Sodick Probes Unauthorized Server Access After Cyber Intrusion
Sodick ( ($JP:6143) ) has provided an update. Sodick has disclosed that it dete...
05-21 15:54
Transcript: Intrusion Q1 2026 Earnings Conference Call
Intrusion (NASDAQ:INTZ) reported first-quarter financial results on Thursday. T...
05-15 06:17
Earnings Scheduled For May 14, 2026
Companies Reporting Before The Bell • Urban One (NASDAQ:UONEK) is expected to r...
05-14 19:11
Travel Expert Reports Cyber Intrusion but Says Operations Remain Stable
The latest update is out from Travel Expert (Asia) Enterprises Limited ( ($HK:1...
04-20 17:39
Johnson Controls considers $4.5B in divestitures - Bloomberg
Johnson Controls (JCI) is evaluating options, including a possible sale of two businesses in its security division that could be worth as much as $4.5 billion. Johnson Controls (JCI) is working with a...
04-16 04:51
美股大行评级 | 小摩上调Lumentum控股目标价从565美元升至950美元；大小摩齐上调美国铝业目标价
今日重点评级关注：Ascendiant Capital：维持RenovoRx"买入"评级，目标价从13美元升至13.5美元；Ascendiant Capital：维持Lucid Diagnostics"买入"评级，目标价从8.25美元升至9美元
04-10 18:27
Intrusion Secures New $3.23 Million Secured Promissory Note
Intrusion ( ($INTZ) ) has shared an update. On April 6, 2026, Intrusion Inc. en...
04-10 04:34
Iran's Parliament Speaker Ghalibaf Posts On X: 'Statement On The Violation Of Three Key Clauses Of The 10-Point Proposal (Agreed Framework) Before The Start Of Negotiations'; Notes Lebanon Ceasefire, Drone Intrusions, Iran's Right to Uranium Enrichment
https://x.com/mb_ghalibaf/status/2041943537386958858/photo/1
04-09 02:38
美股大行评级 | 潜在涨幅172.14%！Alumis获Oppenheimer上调目标价至55美元；摩根大通首予希捷科技"超配"评级，目标价525美元
今日重点评级关注：Oppenheimer：维持Alumis"跑赢大市"评级，目标价从50美元升至55美元；美银证券：维持Rocket Pharmaceuticals"买入"评级，目标价从8美元升至9美元
03-31 16:30
